100% Online & Most Affordable Weight Loss Care






Wegovy is a prescription-based treatment designed to support weight loss. It contains semaglutide, which mimics a hormone naturally produced by the body, helping to regulate hunger signals and promote a sense of satiety. This makes it easier to manage food intake, ultimately supporting weight reduction.
One Wegovy pen contains four doses, so a pen lasts for 4 weeks.
Price:
£168.00
Wegovy (semaglutide) is privately prescribed at Weight Loss Pharmacy following an online medical assessment and clinician review. Simply complete our online consultation form. If you meet the eligibility criteria, you may proceed with placing an order for Wegovy weight loss injection pens.

GMC No. 7099398
Dr Mihaela C. is a highly experienced General Practitioner registered with the General Medical Council (GMC No. 7099398), with a strong background in both NHS and private healthcare across the UK
Last reviewed on: 01/12/2025
Start your weight loss journey by completing a short consultation to see if Wegovy (semaglutide) is right for you. Get the prescription weight loss injection delivered discreetly to you.

Wegovy treatment helps you effectively lose up to 15% of your body weight, depending on how well you adhere to the treatment.
Based on the results of a peer-reviewed clinical study of 2539 participants.
Providing patients with safe, medically supervised access to clinically-tested Wegovy weight loss injection.

Wegovy offers an effective approach to weight management, specially formulated to support your body’s natural processes. This prescription-only weight loss medication contains semaglutide, a GLP-1 receptor agonist that mimics the body’s natural appetite-regulating hormones. By working with your body’s natural systems, Wegovy medication helps you control hunger and stay satisfied with fewer calories, ultimately promoting lasting weight loss.
Unlike quick fixes, Wegovy supports sustainable weight loss by enhancing appetite regulation, improving satiety, and promoting healthier food choices. It's most effective when combined with a balanced diet and regular physical activity, offering a holistic approach to weight management.
Wegovy injection works by mimicking GLP-1 , a hormone that your body naturally releases after eating. This hormone plays an essential role in managing appetite, blood sugar levels, and stomach emptying. The medication effectively reduces hunger, helping you feel fuller after smaller meals, while also slowing the rate at which food leaves the stomach, prolonging feelings of fullness.
This combination of effects allows you to eat less, feel satisfied, and make better food choices, which in turn supports weight loss over time. For optimal results, Wegovy should be used alongside a calorie-controlled diet and regular exercise.
Clinical studies show that most adults using Wegovy achieved significant weight loss. When combined with a balanced diet and exercise, they lost at least 5% of their initial body weight.
Wegovy offers several advantages for individuals seeking to manage their weight and improve overall health:
Wegovy has shown noticeable results in clinical trials, helping individuals achieve meaningful weight loss. In a 68-week study, participants using the 2.4 mg maintenance dose lost between 15% and 17% of their body weight, far outperforming the 2.4% loss observed in the placebo group.
This injectable treatment works effectively when paired with a balanced diet and regular physical activity, amplifying its effects and promoting long-term weight management.
The clinical trials revealed impressive outcomes for Wegovy users:
Wegovy not only aids in weight loss but also offers other health benefits, including a reduction in waist circumference and a lowering of systolic blood pressure.
Disclaimer: Weight loss results are based on clinical trials, but individual outcomes may vary.
The amount of weight lost with Wegovy can vary depending on the dosage. Higher doses typically lead to more significant weight loss outcomes.

Wegovy doesn't produce instant weight loss — it begins working inside your body within days, but noticeable effects take time. You'll usually feel reduced hunger within the first couple of weeks, and many people start to see visible weight loss around 4–8 weeks after starting treatment as the dose gradually increases. Full, meaningful results often take several months of consistent weekly injections and lifestyle changes.
Yes, Wegovy is safe when prescribed and monitored by a healthcare professional. It is a licensed weight-loss medication approved in the UK, designed for use under medical supervision. While generally well-tolerated, some users may experience mild side effects like nausea, headache, or digestive issues, which often improve with time. Serious risks, though rare, can include gallbladder problems or pancreatitis, especially in individuals with certain health conditions. Always consult a doctor to assess suitability and manage any potential risks.
Currently, Wegovy does not have a generic alternative available in the UK. It remains under patent protection, and a generic version may be available after the patent expires in 2031. For now, Wegovy is only available in its branded form with a prescription.
Wegovy isn't just effective for weight loss; it also has cardiovascular benefits. Clinical studies show that people using Wegovy saw a 20% reduction in the risk of major heart-related events, including heart attacks and strokes. This makes it a powerful option for those dealing with obesity-related cardiovascular risks.
Wegovy is typically prescribed to adults with a BMI over 30, or over 27 if they have weight-related health concerns like high blood pressure, type 2 diabetes, or high cholesterol. Our UK licensed clinician will assess your eligibility based on your medical history and weight loss goals.
To determine if a Wegovy is right for you, a licensed healthcare provider will conduct a detailed assessment. This weight loss treatment is generally recommended for adults who meet one of the following criteria: A Body Mass Index (BMI) of 30 or higher, or A BMI of 27 or higher, alongside health conditions related to weight, such as:
The decision to prescribe weight loss pen is based on this thorough evaluation, ensuring the treatment is suited to your specific health needs. Before starting treatment, make sure to carefully review the patient information leaflet.
Wegovy is not suitable for everyone. If you are pregnant, planning to become pregnant, or breastfeeding, it is not recommended due to the lack of safety data during pregnancy and lactation.
It is also not advised for individuals with a BMI below 27 unless there is a weight-related medical condition. Additionally, people with an allergy to semaglutide or any other ingredients in weight loss pen should avoid this medication.
If you have any of the following health conditions, consult with our clinician before starting Wegovy medication:
Adults living with type 2 diabetes may use Wegovy, but medical supervision plays a key role. If you already take diabetes medications, Our healthcare professional will closely review your treatment plan and monitor your response to avoid issues such as low blood sugar. Suitability always depends on your individual health profile.
Yes. Wegovy is prescribed for weight loss in adults without diabetes as long as they meet eligibility criteria (commonly BMI ≥ 30, or BMI ≥ 27 with a weight-related condition) and pass a clinician review. It was originally developed for type 2 diabetes, but it’s now used specifically for weight management in suitable patients.
Our healthcare professionals use a step-wise schedule where you start low and increase every 4 weeks until you reach a maintenance dose.
The maintenance may be 1.7 mg or 2.4 mg, depending on what our UK licensed clinician decides is right for you.
Wegovy is prescribed using a step-by-step dosing plan, designed to help your body adjust comfortably while ensuring maximum effectiveness. Starting at a low dose, the medication gradually increases to a maintenance dose of 2.4 mg, helping to minimise side effects while promoting steady weight loss.
This structured approach allows the body to acclimate to the medication, ensuring that weight loss happens safely and progressively under medical supervision.

The "right" dose is typically the one that delivers steady progress while still feeling tolerable day-to-day — without pushing through side effects unnecessarily. Treatment is not one-size-fits-all, and our healthcare professional may keep you at a lower dose if you're doing well on it.
Dose increases are usually planned every 4 weeks, but adjustments can happen based on how you feel. If side effects are troublesome, the UK licensed healthcare professional may recommend staying on the same dose longer rather than moving up on schedule. Only change dose under clinical advice.
Yes, you can take your dose a day early, but ensure that at least 3 days have passed since your last injection. However, it’s important to confirm any adjustments with our clinician to make sure it’s safe for you.
If you forget to take your Wegovy weight loss injections and it’s been 5 days or less, administer the dose as soon as you remember. Afterwards, continue with your next injection on the usual day, even if it’s only a few days apart.
However, if more than 5 days have passed, skip the missed dose and resume your regular schedule. Never attempt to take a double dose to make up for the missed one, as it could increase the risk of side effects.
Consistently missing doses can impact the effectiveness of your treatment. If you miss two or more doses, consult our healthcare provider. They may advise restarting the treatment at a lower dose, especially if you’ve experienced any stomach-related discomfort.
The length of time you need to take Wegovy depends on your individual weight loss goals. Most people use it until they reach their desired weight, with some choosing to stay on the medication to help maintain their results. After six months, Our healthcare professional will review your progress to determine if continuing is appropriate.
If you’ve lost at least 5% of your starting body weight and are experiencing no major side effects, you may continue using medication as part of your long-term weight management plan.
Most people take Wegovy weekly for at least 6–12 months, with continuation beyond that depending on how much more weight loss and health improvements you want to achieve.
In the UK, treatment may be continued as long as it’s considered safe and effective, but many plans start with a gradual dose escalation over the first 16–20 weeks before staying at a maintenance dose until your goals are reached.
Stopping too early often leads to weight regain, so licensed healthcare professionals typically recommend ongoing use until desired weight and lifestyle changes are sustained.
Wegovy is a subcutaneous injection, which means it’s injected just under the skin, typically once a week. You can take it with or without food, but to maintain consistency, it’s ideal to administer the injection at the same time each week. Each pen contains four doses, enough for one month of treatment. Once you finish the four doses, you’ll need to start a new pen.
Here’s a simple guide to help you administer your weight loss pen:
Wegovy is injected just beneath the skin (subcutaneously), typically in the abdomen, upper legs, or upper arms. To reduce any discomfort or irritation, rotate the injection sites weekly. This ensures you don’t experience soreness from injecting in the same spot repeatedly, promoting a smoother injection experience.

This keeps disposal safe, hygienic, and compliant with UK clinical waste guidance.
Yes. Wegovy is supplied as a pre-filled injection pen. The medication comes ready to use, and injection needles can be included with your order if required.
There is no need to source needles independently. If appropriate, needles and a sharps disposal bin can be supplied during your clinical assessment.
When storing Wegovy, it’s important to keep the medication in the fridge before use. The ideal temperature is between 2°C and 8°C. Make sure to store it away from the cooling element. After the pen is opened, it can be kept at room temperature below 30°C, or you can continue storing it in the fridge. If you don’t use the pen within 6 weeks, it should be discarded. Always keep the cap on to protect it from light.
Once opened, Wegovy can stay out of the fridge for up to 6 weeks, as long as it doesn’t exceed 30°C. Keep the pen in its original packaging to prevent light exposure and store it in a cool, dry place.
When travelling, always carry your Wegovy pen in your hand luggage to avoid temperature fluctuations in the aircraft hold. Store the pen in a cooler to maintain the recommended temperature range (2°C to 8°C). Remember to bring your Wegovy prescription and adhere to airline regulations regarding medication transport.
Most people notice appetite reduction within days to 1–2 weeks, and it commonly becomes more noticeable within the first 4 weeks. For many, appetite control can feel stronger by weeks 9–12 as dosing increases.
If you’re still feeling hungry on Wegovy, several factors could be at play, such as not reaching your optimal dose or not following a balanced diet. It’s crucial to maintain a proper nutritional intake while on Wegovy, as being in a calorie deficit without proper nutrition can hinder your progress. If hunger continues, discuss other treatment options With our clinician.
Wegovy is non-addictive, and it’s safe to stop once you reach a healthy weight. However, you may experience an increase in appetite as the medication’s effects diminish. Research shows that many people regain some of the weight lost once they stop using the injection, especially within the first year.
To prevent this, continue healthy habits such as a balanced, calorie-controlled diet and regular exercise. While weight loss treatment can help you lose weight, sustaining those results requires ongoing lifestyle changes.
Weight regain is possible after stopping Wegovy, especially if diet and activity changes aren’t maintained. On average, people may regain a large proportion of the weight lost (one provider cites around two-thirds regained on average), but results vary person to person.
Wegovy can cause side effects, although many people experience minimal or no issues. Some side effects are mild and temporary, often improving as the body adjusts to the medication.
While less common, there are serious reactions to be aware of. These include:
It's important to monitor for these and seek immediate medical help if necessary. For detailed information, please consult your patient information leaflet..
Most side effects are short-lived and improve as your body adjusts — commonly a few days to a few weeks. They are most likely in the first month. They can return after a dose increase, then usually settle again.
Wegovy is approved for longer-term use, and there’s no fixed maximum duration, but it should be reviewed regularly so the benefits continue to outweigh the risks. Longer-term or less common risks discussed by UK providers include issues like gallstones, and rare but serious effects such as pancreatitis or severe allergic reactions; some guidance also flags monitoring for thyroid swelling, especially if you have thyroid disease.
If weight loss feels rapid, avoid undereating. Stick to small, regular meals and stay well hydrated to support safe progress. Follow the prescribed dosing schedule. Increasing doses faster than advised can raise the risk of side effects. Rapid loss can happen in good responders, but it’s sensible to check in with your healthcare professional if you’re unsure. Seek urgent medical advice if fast weight loss is accompanied by persistent vomiting, severe abdominal pain, dizziness, or signs of dehydration.
Many of the side effects associated with Wegovy are temporary and typically subside as your body adjusts. To help manage common effects like nausea, try staying hydrated, eating smaller meals throughout the day, and avoiding spicy or heavy foods.
If side effects persist or become more intense, contact our healthcare provider for guidance. Should you experience severe symptoms, such as intense abdominal pain or difficulty breathing, seek emergency medical attention immediately.
Wegovy is a powerful weight loss tool, but it’s essential to use it with caution. Before starting Wegovy, ensure you have a full understanding of potential risks and consult with a healthcare provider if you have any of the following:
Do not use Wegovy if you are pregnant, planning to become pregnant, or breastfeeding, as its safety during these conditions has not been established. The safety of injection during pregnancy and lactation has not been established. Discontinue use at least two months before attempting to conceive. If you suspect you may be pregnant, stop taking medication and seek advice from our healthcare provider.
Do not use Wegovy while breastfeeding. The effects of the medication on breast milk are unknown, and it’s important to prioritise the health and safety of both you and your baby.
While using Wegovy, contraception is advised to prevent pregnancy. Although Wegovy does not impact the effectiveness of oral contraceptives, side effects such as vomiting or diarrhea may reduce their absorption. In such cases, you may need to use alternative contraception methods to ensure protection.
Always ensure you’re fully informed and consult our healthcare professional to assess if weight loss treatment is the right fit for your health needs. Your safety and well-being are our priority.
It’s crucial to discuss any current medications or supplements with our healthcare provider before starting Wegovy for weight loss. This helps our clinician evaluate potential interactions and adjust your treatment plan to ensure it’s both safe and effective for you.
If you’re managing diabetes with insulin or sulfonylureas, combining them with a weight loss injection may increase the risk of low blood sugar (hypoglycemia). Our UK licensed clinician may suggest more frequent blood sugar monitoring and adjust your diabetes medication accordingly.
Additionally, avoid using weight loss medication with other GLP-1 receptor agonists like Mounjaro or liraglutide. Combining these medications could result in excessive dosing, raising the risk of unwanted side effects. Always consult our healthcare provider if you’re using other treatments to ensure they are compatible with Wegovy.
Yes, sometimes — but only under clinician supervision. Wegovy is not a replacement for insulin, and using it alongside insulin or other diabetes medicines can raise the risk of low blood sugar (hypoglycaemia). Our prescriber may adjust doses and advise closer glucose monitoring.
No. You should not use Wegovy alongside another GLP-1 receptor agonist (for example, medicines containing semaglutide or other GLP-1 treatments). This is effectively "doubling up" and significantly increases the risk of side effects.
You can conveniently buy Wegovy online through a trusted service. A licensed healthcare provider will assess your health status and determine if Wegovy is the right fit for your weight loss goals. If appropriate, a wegovy prescription will be issued, and Wegovy will be delivered directly to your door in discreet packaging, ensuring your privacy and convenience.
Wegovy is available in the UK only through regulated services that are legally authorized to prescribe prescription-only medicines. You can access it via:
Wegovy is not sold over the counter and should never be purchased from unregulated sellers.
Getting a Wegovy prescription online is simple. Complete our online consultation, and our licensed medical team will assess your eligibility. If you meet the criteria, Wegovy will be prescribed, and you can have it delivered discreetly to your home.
To request Wegovy from Online Weight Loss Clinic:
Getting a Wegovy prescription online is simple. Complete our online consultation and our licensed medical team will assess your eligibility. If you meet the criteria, Wegovy will be prescribed and delivered discreetly to your home.
To request Wegovy from Online Weight Loss Clinic:
Prescription approval is based on clinical suitability and is not guaranteed.
First-time orders follow a structured process to ensure Wegovy is supplied safely and in line with UK regulations:
This process ensures Wegovy is supplied safely and in line with UK prescribing regulations. Each pack contains four once-weekly injections, covering one month of treatment. Prices reflect the prescribed dose strength and may vary based on availability. Wegovy is supplied only following a successful clinical assessment and prescription approval.
The cost of Wegovy in the UK depends on the prescribed dose. Based on current in-stock pricing, monthly costs are:
| Dose | Supply | Monthly Cost |
|---|---|---|
| 0.25 mg | 4 weekly doses | £168.00 |
| 0.5 mg | 4 weekly doses | £189.00 |
| 1.0 mg | 4 weekly doses | £197.00 |
| 1.7 mg | 4 weekly doses | £247.00 |
| 2.4 mg | 4 weekly doses | £297.00 |
Each pack contains four once-weekly injections, covering one month of treatment. Prices reflect the dose strength prescribed and may change based on availability. Wegovy is supplied only after a successful clinical assessment and prescription approval.
Wegovy and Mounjaro are both injectable weight-loss medications, but they use different active ingredients and work slightly differently. Wegovy contains semaglutide, which mimics the GLP-1 hormone to reduce appetite and slow digestion. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP hormones, potentially leading to stronger appetite control and greater weight loss in clinical studies. Their dosing schedules and effects vary, and they are not interchangeable without medical guidance.
While both help with weight management, Wegovy uses semaglutide and is given once weekly, whereas Saxenda uses liraglutide and must be injected daily. Wegovy stays active in the body much longer, allowing weekly dosing, whereas Saxenda's shorter activity means daily administration is required.
Although Wegovy and Ozempic contain the same active ingredient — semaglutide — they serve different purposes. Wegovy is prescribed for weight loss, while Ozempic is used for managing type 2 diabetes. They also differ in dosage, with Wegovy being more focused on appetite regulation for weight management.
Switching from Mounjaro to Wegovy is straightforward. After evaluating your needs and progress, our clinical team will guide you through the process and adjust your dosage accordingly. This transition can usually take place within a week to ensure a seamless continuation of your weight loss journey.
There is no single "best" weight loss injection for everyone. The right option depends on your BMI, medical history, and prescriber assessment.
If Wegovy isn't the right fit for you, we offer other treatments such as Mounjaro and Nevolat. These medications also work by regulating blood sugar and controlling appetite. Our prescribing team will assess your specific needs and help you explore other weight loss options that suit your health and lifestyle.
Active substance
Mechanism of action
Dose adjustment pattern
Administration frequency
Weight loss in studies
Prescription required
| Comparison point | Wegovy | Mounjaro | Saxenda |
|---|---|---|---|
| Active substance | Semaglutide | Tirzepatide | Liraglutide |
| Mechanism of action | Helps reduce hunger, delays digestion, and increases feelings of fullness | Regulates appetite, slows digestion, enhances fullness, and supports blood sugar control | Controls appetite, slows digestion, and promotes longer-lasting satiety |
| Dose adjustment pattern | Increases at 4-week intervals | Increases at 4-week intervals | Increases every week |
| Administration frequency | Once per week | Once per week | Once per day |
| Weight loss in studies | Average losses up to 15% of body weight | Average losses up to 20% of body weight | Average losses between 5% and 10% |
| Prescription required | Yes | Yes | Yes |
The Wegovy patient information leaflet. (PIL) is provided with your prescription medication packaging when your treatment is dispensed by Weight Loss Pharmacy. It contains detailed guidance on how Wegovy works, dosing instructions, and safety information. Read it fully before starting treatment, as required for all UK-licensed prescription medicines.
Wegovy treatment includes a UK-licensed, once-weekly semaglutide injection, with clear information on how it works to reduce appetite and cravings. You'll also receive:
Let’s talk about how we can work together to make healthcare work for all of us.